| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |